ClinicalTrials.Veeva

Menu

US National OCS Heart Perfusion (OHP) Registry

TransMedics logo

TransMedics

Status

Enrolling

Conditions

Heart Transplant

Treatments

Device: OCS Heart

Study type

Observational

Funder types

Industry

Identifiers

NCT05915299
OCS-HEART-OHP-II

Details and patient eligibility

About

This Registry is a sponsor initiated, multi-center, observational post-approval registry with independent academic oversight.

Full description

The objective of this US National OHP Registry is to collect data on the post-transplant clinical outcomes of all donor hearts preserved and assessed on the OCS Heart System and to document the performance of the OCS Heart device in the real-world setting after FDA approval in the US.

The US National OHP Registry will enroll all heart transplant recipients who are transplanted with an OCS-perfused donor heart in the Registry. Patients' clinical outcomes will be followed up to five years post-transplant, loss to follow up, or death, whichever occurs first.

Enrollment

100,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • N/A

Exclusion criteria

  • N/A

Trial design

100,000 participants in 1 patient group

OCS Heart Transplant Recipients
Description:
All heart transplant recipients who are transplanted with an OCS perfused donor heart are eligible for this registry.
Treatment:
Device: OCS Heart

Trial contacts and locations

37

Loading...

Central trial contact

Kausar Qidwai; Raicca Haqqi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems